# UNIVEST FINANCIAL Corp: financial statements, quarterly

UVSP · Nasdaq · CIK 102212 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uvsp.md) · [Financials](/companies/uvsp/financials.md) · [Filings](/companies/uvsp/filings.md) · [Insiders](/companies/uvsp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uvsp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [77.1](/filings/0000102212-25-000019.md) | [72.0](/filings/0001628280-25-036392.md) | [73.4](/filings/0000102212-25-000028.md) | [76.8 d](/filings/0000102212-26-000012.md) | [79.2](/filings/0000102212-26-000028.md) | [81.0](/filings/0000102212-26-000037.md) | [83.2](/filings/0000102212-25-000028.md) | [84.6 d](/filings/0000102212-26-000012.md) | [87.5](/filings/0000102212-26-000028.md) | [84.4](/filings/0000102212-26-000037.md) |
| Interest expense | $m | [43.5](/filings/0000102212-23-000062.md) | [48.5 d](/filings/0000102212-25-000006.md) | [47.1](/filings/0000102212-24-000038.md) | [48.8](/filings/0000102212-24-000052.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [4.3](/filings/0000102212-24-000059.md) | [4.1 d](/filings/0000102212-26-000012.md) | [5.3](/filings/0000102212-25-000019.md) | [4.5](/filings/0001628280-25-036392.md) | [4.8](/filings/0000102212-25-000028.md) | [4.8 d](/filings/0000102212-26-000012.md) | [5.2](/filings/0000102212-26-000028.md) | [5.0](/filings/0000102212-26-000037.md) | [6.4](/filings/0000102212-25-000028.md) | [6.0 d](/filings/0000102212-26-000012.md) | [6.4](/filings/0000102212-26-000028.md) | [5.6](/filings/0000102212-26-000037.md) |
| Net income | $m | [17.0](/filings/0000102212-24-000059.md) | [16.3 d](/filings/0000102212-26-000012.md) | [20.3](/filings/0000102212-25-000019.md) | [18.1](/filings/0001628280-25-036392.md) | [18.6](/filings/0000102212-25-000028.md) | [18.9 d](/filings/0000102212-26-000012.md) | [22.4](/filings/0000102212-26-000028.md) | [20.0](/filings/0000102212-26-000037.md) | [25.6](/filings/0000102212-25-000028.md) | [22.7 d](/filings/0000102212-26-000012.md) | [27.1](/filings/0000102212-26-000028.md) | [23.0](/filings/0000102212-26-000037.md) |
| Diluted EPS | $ per share | [0.58](/filings/0000102212-24-000059.md) | not reported | [0.69](/filings/0000102212-25-000019.md) | [0.62](/filings/0001628280-25-036392.md) | [0.63](/filings/0000102212-25-000028.md) | not reported | [0.77](/filings/0000102212-26-000028.md) | [0.69](/filings/0000102212-26-000037.md) | [0.89](/filings/0000102212-25-000028.md) | not reported | [0.96](/filings/0000102212-26-000028.md) | [0.82](/filings/0000102212-26-000037.md) |
| Basic EPS | $ per share | [0.58](/filings/0000102212-24-000059.md) | not reported | [0.69](/filings/0000102212-25-000019.md) | [0.62](/filings/0001628280-25-036392.md) | [0.64](/filings/0000102212-25-000028.md) | not reported | [0.77](/filings/0000102212-26-000028.md) | [0.69](/filings/0000102212-26-000037.md) | [0.89](/filings/0000102212-25-000028.md) | not reported | [0.97](/filings/0000102212-26-000028.md) | [0.83](/filings/0000102212-26-000037.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [7,828](/filings/0000102212-24-000059.md) | [7,781](/filings/0000102212-25-000006.md) | [7,747](/filings/0000102212-24-000038.md) | [7,855](/filings/0000102212-24-000052.md) | [8,206](/filings/0000102212-24-000059.md) | [8,128](/filings/0000102212-26-000012.md) | [7,975](/filings/0000102212-25-000019.md) | [7,939](/filings/0001628280-25-036392.md) | [8,574](/filings/0000102212-25-000028.md) | [8,437](/filings/0000102212-26-000037.md) | [8,142](/filings/0000102212-26-000028.md) | [8,203](/filings/0000102212-26-000037.md) |
| Total liabilities | $m | [7,021](/filings/0000102212-23-000062.md) | [6,941](/filings/0000102212-25-000006.md) | [6,903](/filings/0000102212-24-000038.md) | [7,001](/filings/0000102212-24-000052.md) | [7,329](/filings/0000102212-24-000059.md) | [7,241](/filings/0000102212-26-000012.md) | [7,072](/filings/0000102212-25-000019.md) | [7,022](/filings/0001628280-25-036392.md) | [7,640](/filings/0000102212-25-000028.md) | [7,494](/filings/0000102212-26-000037.md) | [7,190](/filings/0000102212-26-000028.md) | [7,249](/filings/0000102212-26-000037.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [14.7](/filings/0000102212-23-000062.md) | [6.3](/filings/0000102212-25-000006.md) | [4.8](/filings/0000102212-24-000038.md) | [11.8](/filings/0000102212-24-000052.md) | [8.3](/filings/0000102212-24-000059.md) | [11.2](/filings/0000102212-26-000012.md) | [4.0](/filings/0000102212-25-000019.md) | [6.3](/filings/0001628280-25-036392.md) | [12.0](/filings/0000102212-25-000028.md) | [24.4](/filings/0000102212-26-000037.md) | [26.2](/filings/0000102212-26-000028.md) | [18.8](/filings/0000102212-26-000037.md) |
| Shareholders' equity | $m | [807](/filings/0000102212-24-000059.md) | [839](/filings/0000102212-26-000012.md) | [844](/filings/0001628280-25-036392.md) | [854](/filings/0000102212-25-000028.md) | [877](/filings/0000102212-25-000028.md) | [887](/filings/0000102212-26-000037.md) | [903](/filings/0000102212-26-000037.md) | [917](/filings/0000102212-26-000037.md) | [933](/filings/0000102212-25-000028.md) | [943](/filings/0000102212-26-000037.md) | [952](/filings/0000102212-26-000037.md) | [954](/filings/0000102212-26-000037.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [21.8 d](/filings/0000102212-24-000059.md) | [27.9 d](/filings/0000102212-26-000012.md) | [11.6](/filings/0000102212-25-000019.md) | [(3.4) d](/filings/0001628280-25-036392.md) | [38.9 d](/filings/0000102212-25-000028.md) | [28.0 d](/filings/0000102212-26-000012.md) | [15.6](/filings/0000102212-26-000028.md) | [23.3 d](/filings/0000102212-26-000037.md) | [32.0 d](/filings/0000102212-25-000028.md) | [30.7 d](/filings/0000102212-26-000012.md) | [22.1](/filings/0000102212-26-000028.md) | [24.0 d](/filings/0000102212-26-000037.md) |
| Capital expenditure | $m | [0.9 d](/filings/0000102212-24-000059.md) | [1.5 d](/filings/0000102212-26-000012.md) | [1.0](/filings/0000102212-25-000019.md) | [0.8 d](/filings/0001628280-25-036392.md) | [0.6 d](/filings/0000102212-25-000028.md) | [0.6 d](/filings/0000102212-26-000012.md) | [1.9](/filings/0000102212-26-000028.md) | [1.3 d](/filings/0000102212-26-000037.md) | [0.6 d](/filings/0000102212-25-000028.md) | [0.7 d](/filings/0000102212-26-000012.md) | [0.6](/filings/0000102212-26-000028.md) | [1.1 d](/filings/0000102212-26-000037.md) |
| Dividends paid | $m | [6.2 d](/filings/0000102212-24-000059.md) | [6.2 d](/filings/0000102212-26-000012.md) | [6.2](/filings/0000102212-25-000019.md) | [6.4 d](/filings/0001628280-25-036392.md) | [6.1 d](/filings/0000102212-25-000028.md) | [6.1 d](/filings/0000102212-26-000012.md) | [6.4](/filings/0000102212-26-000028.md) | [6.4 d](/filings/0000102212-26-000037.md) | [6.3 d](/filings/0000102212-25-000028.md) | [6.3 d](/filings/0000102212-26-000012.md) | [6.5](/filings/0000102212-26-000028.md) | [6.4 d](/filings/0000102212-26-000037.md) |
| Share repurchases | $m | [0.0 d](/filings/0000102212-24-000059.md) | [0.5 d](/filings/0000102212-26-000012.md) | [6.5](/filings/0000102212-25-000019.md) | [4.0 d](/filings/0001628280-25-036392.md) | [4.2 d](/filings/0000102212-25-000028.md) | [4.2 d](/filings/0000102212-26-000012.md) | [6.5](/filings/0000102212-26-000028.md) | [4.9 d](/filings/0000102212-26-000037.md) | [7.8 d](/filings/0000102212-25-000028.md) | [15.4 d](/filings/0000102212-26-000012.md) | [11.9](/filings/0000102212-26-000028.md) | [16.6 d](/filings/0000102212-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [29.4](/filings/0000102212-23-000062.md) | [29.5](/filings/0000102212-24-000038.md) | [29.5](/filings/0000102212-24-000052.md) | [29.6](/filings/0000102212-24-000059.md) | [29.6](/filings/0000102212-25-000019.md) | [29.4](/filings/0001628280-25-036392.md) | [29.3](/filings/0000102212-25-000028.md) | [29.3](/filings/0000102212-26-000028.md) | [29.0](/filings/0000102212-26-000037.md) | [29.0](/filings/0000102212-25-000028.md) | [28.3](/filings/0000102212-26-000028.md) | [28.0](/filings/0000102212-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 27,580,768 at 2026-07-27, from the cover of the [10-Q filed 2026-07-28](/filings/0000102212-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.